JP2021535168A5 - - Google Patents

Info

Publication number
JP2021535168A5
JP2021535168A5 JP2021511593A JP2021511593A JP2021535168A5 JP 2021535168 A5 JP2021535168 A5 JP 2021535168A5 JP 2021511593 A JP2021511593 A JP 2021511593A JP 2021511593 A JP2021511593 A JP 2021511593A JP 2021535168 A5 JP2021535168 A5 JP 2021535168A5
Authority
JP
Japan
Prior art keywords
composition
subject
sequence
virus
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021511593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021535168A (ja
JP7587275B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048985 external-priority patent/WO2020047368A1/en
Publication of JP2021535168A publication Critical patent/JP2021535168A/ja
Publication of JP2021535168A5 publication Critical patent/JP2021535168A5/ja
Priority to JP2024091954A priority Critical patent/JP7807105B2/ja
Application granted granted Critical
Publication of JP7587275B2 publication Critical patent/JP7587275B2/ja
Priority to JP2026000974A priority patent/JP2026082833A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021511593A 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法 Active JP7587275B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024091954A JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法
JP2026000974A JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862724780P 2018-08-30 2018-08-30
US62/724,780 2018-08-30
PCT/US2019/048985 WO2020047368A1 (en) 2018-08-30 2019-08-30 Methods of treating or preventing amyotrophic lateral sclerosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024091954A Division JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Publications (3)

Publication Number Publication Date
JP2021535168A JP2021535168A (ja) 2021-12-16
JP2021535168A5 true JP2021535168A5 (cg-RX-API-DMAC7.html) 2022-06-13
JP7587275B2 JP7587275B2 (ja) 2024-11-20

Family

ID=69643060

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021511593A Active JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法
JP2026000974A Pending JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法
JP2026000974A Pending JP2026082833A (ja) 2018-08-30 2026-01-06 筋萎縮性側索硬化症の治療方法または予防方法

Country Status (9)

Country Link
US (2) US12508327B2 (cg-RX-API-DMAC7.html)
EP (1) EP3844285A4 (cg-RX-API-DMAC7.html)
JP (3) JP7587275B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210053305A (cg-RX-API-DMAC7.html)
CN (1) CN112673107A (cg-RX-API-DMAC7.html)
AU (2) AU2019328337B2 (cg-RX-API-DMAC7.html)
CA (1) CA3107612A1 (cg-RX-API-DMAC7.html)
IL (1) IL280965B2 (cg-RX-API-DMAC7.html)
WO (1) WO2020047368A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7587275B2 (ja) * 2018-08-30 2024-11-20 ローワン・ユニバーシティ 筋萎縮性側索硬化症の治療方法または予防方法
WO2025240562A1 (en) * 2024-05-15 2025-11-20 Woolsey Pharmaceuticals, Inc. Method of treating amyotrophic lateral sclerosis with trimetazidine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
FR2923962B1 (fr) * 2007-11-20 2009-11-20 Valeo Sys Controle Moteur Sas Circuit elevateur de tension
DK2561073T3 (en) * 2010-04-23 2016-12-12 Univ Massachusetts Aav vectors targeted to central nervous system and methods of use thereof
EP2861733B1 (en) * 2012-05-30 2020-10-07 Rowan University Metabolic therapy for oxidative stress in the brain through targeted neuronal catabolism of n-acetyl-aspartic acid
US11413356B2 (en) * 2016-04-15 2022-08-16 University Of Massachusetts Methods and compositions for treating metabolic imbalance
JP7587275B2 (ja) 2018-08-30 2024-11-20 ローワン・ユニバーシティ 筋萎縮性側索硬化症の治療方法または予防方法

Similar Documents

Publication Publication Date Title
JP2024133479A5 (cg-RX-API-DMAC7.html)
JP2020518259A5 (cg-RX-API-DMAC7.html)
RU2019103488A (ru) Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
JP2022519623A5 (cg-RX-API-DMAC7.html)
JP2023540054A5 (cg-RX-API-DMAC7.html)
JP2019524090A5 (cg-RX-API-DMAC7.html)
US20250057899A1 (en) Gene therapy for ciliopathies
CN117126829A (zh) 基因构建体、表达载体、药物组合物及其用途
WO2009052737A1 (en) Medicament for preventing and controlling alzheimer's disease
US20250099554A1 (en) Compositions and methods of fas inhibition
JP2021533126A (ja) 臓器機能を制御するための遺伝子治療方法
JP2024545186A5 (cg-RX-API-DMAC7.html)
US10639351B2 (en) Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
US20220378942A1 (en) Compositions and methods for treating alzheimer's disease
JP2023513487A5 (cg-RX-API-DMAC7.html)
CN121057823A (zh) 体内修饰神经元以治疗和/或预防肌萎缩性侧索硬化(als)的方法
US12630840B2 (en) One-step gene therapy for Duchenne muscular dystrophy via gene replacement and anti-inflammation
EP3436078B1 (en) Methods and compositions for the treatment of als
JP2022525136A5 (cg-RX-API-DMAC7.html)
US20200297868A1 (en) Methods and compositions for the treatment of als
Landhuis The gene fix
US20230279434A1 (en) Methods and compositions for the treatment of als
CN118909979A (zh) 一种重组腺相关病毒AAV-Lec及其制备方法和应用
JP2025540499A (ja) 色素上皮由来因子ペプチドおよび網膜変性症を処置するための使用
WO2018069422A1 (en) Methods and pharmaceutical compositions for the treatment of non-alcoholic fatty liver disease